Janssen Vaccines
Company type
2000
Ronald Brus (CEO), Jan Pieter Oosterveld (Chairman of the supervisory board)
Vaccines and antibodies
Janssen Vaccines, formerly Crucell, is a biotechnology company specializing in vaccines and biopharmaceutical technologies. It was formed when Johnson & Johnson acquired the Dutch biotech company Crucell based in Leiden and placed it in their pharmaceutical division.